One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Monkeypox: a global wake-up call
doi : 10.1016/S0140-6736(22)01422-2
Volume 400, Issue 10349, 30 July–5 August 2022, Page 337
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
PujaMehtabcBoghuma KTitanjia
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis
Jean WLiewaMaureenDubreuilab
Lowering LDL cholesterol in clinical practice: time for change?
Layla AAbushamataChristie MBallantynea
The Health and Care Act 2022: challenges and priorities for embedding research in the NHS
Cheng HockTohaRichardHaynesb
A new paradigm is needed for financing the pandemic fund
SimonReid-HenryaJonLidénbChristophBenncDiahSaminarsihdOliviaHerlindadMarÃa Fernanda BustosVenegase
Monkeypox PHEIC decision hoped to spur the world to act
JohnZarocostas
Violence against health workers rises during COVID-19
JacquiThornton
New Dutch regulations to alleviate drug shortages
FerryBiedermann
Perilous two-tier COVID-19 global vaccine roll-out
David NDurrheima
Tobacco company funding and conflict of interest
PhilipPattemoreaRichardEdwardsb
Urgent need to update NICE guidelines on imaging for transient ischaemic attack
ShaneMacSweeneyaGaneshSubramanianbAnnaPodlasekcDorotheeAuerc
Reforms to accelerated approval of new medicines: long overdue
Thomas JHwangacQuoc-DienTrinhabAriadnaTibaudeKerstin NVokingercf
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
ProfAtulDeodharMDaProfFilipVan den BoschMDbProfDenisPoddubnyyMDcProfWalter PMaksymowychMDdProfDésiréevan der HeijdeMDeProfTae-HwanKimMDfMitsumasaKishimotoMDgRicardoBlancoMDhYuanyuanDuanPhDiYihanLiPhDiAileen LPanganMDiPeterWungMDiIn-HoSongMDi
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
ProfByeong-KeukKimMDa*Sung-JinHongMDa*Yong-JoonLeeMDaSoon JunHongMDbProfKyeong HoYunMDcProfBum-KeeHongMDdProfJung HoHeoMDeProfSeung-WoonRhaMDfProfYun-HyeongChoMDgSeung-JunLeeMDaProfChul-MinAhnMDaProfJung-SunKimMDaProfYoung-GukKoMDaProfDonghoonChoiMDaProfYangsooJangMDhProfMyeong-KiHongMDaRACING investigatorsâ€
Calvarium indentations in multiple myeloma and CAR T-cell therapy
JavierMunozMDaJeremyLarsenMDa
Bronchiolitis
ProfStuart RDalzielPhDabcLibbyHaskellMNbcSharonO'BrienBNursdeProfMeredith LBorlandMBBSdfgProfAmy CPlintMDhijProfFranz EBablMDkmnProfEdOakleyMBBSklmn
